Q3 2021 Holdings
Filed 2021-11-15 | 124 holdings | $72.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX)A | COM NEW | 15117B202 | $10.0M | 185,000 | 13.9% |
| Aldeyra Therapeutics Inc(ALDX)A | COM | 01438T106 | $7.6M | 864,020 | 10.5% |
| Cerus Corp(CERS)A | COM | 157085101 | $6.7M | 1,100,000 | 9.3% |
| Cytomx Therapeutics Inc(CTMX)A | COM | 23284F105 | $6.3M | 1,233,642 | 8.7% |
| Arcutis Biotherapeutics Inc(ARQT)A | COM | 03969K108 | $6.1M | 255,000 | 8.5% |
| Caredx Inc(CDNA)A | COM | 14167L103 | $5.7M | 90,000 | 7.9% |
| Castle Biosciences Inc(CSTL)A | COM | 14843C105 | $4.8M | 72,500 | 6.7% |
| Crinetics Pharmaceuticals in(CRNX)A | COM | 22663K107 | $4.1M | 193,000 | 5.6% |
| Bicycle Therapeutics PLC(BCYC)A | SPONSORED ADS | 088786108 | $3.8M | 92,000 | 5.3% |
| Arcturus Therapeutics Hldgs(ARCT)A | COM | 03969T109 | $3.8M | 80,000 | 5.3% |
| Bridgebio Pharma Inc(BBIO)A | COM | 10806X102 | $3.7M | 79,000 | 5.1% |
| Aurinia Pharmaceuticals Inc(AUPH)A | COM | 05156V102 | $3.2M | 144,000 | 4.4% |
| Celcuity Inc(CELC)A | COM | 15102K100 | $2.6M | 145,000 | 3.6% |
| Cardiff Oncology Inc(CRDF)A | COM | 14147L108 | $2.3M | 348,888 | 3.2% |
| Achieve Life Sciences Inc(ACHV)A | COM | 004468500 | $1.0M | 122,000 | 1.4% |
| Oramed Pharmaceuticals Inc(ORMP) | COM NEW | 68403P203 | $12.6K | 493,384 | 3.1% |
| 1847 Goedeker IncA | *W EXP 99/99/999 | 28252C117 | $11.6K | 6,886,600 | 0.0% |
| Bellus Health Inc New(BLU)A | COM NEW | 07987C204 | $11.0K | 1,788,789 | 0.0% |
| CTI Biopharma Corp(CTIC1USD)A | COM | 12648L601 | $9.8K | 3,313,000 | 0.0% |
| Lantheus Hldgs Inc(LNTH)A | COM | 516544103 | $7.4K | 290,000 | 0.0% |
| Xtant MED Hldgs Inc(XTNT)A | COM NEW | 98420P308 | $6.9K | 6,254,458 | 0.0% |
| Verastem IncA | COM | 92337C104 | $6.9K | 2,253,000 | 0.0% |
| Curis Inc(CRISEUR)A | COM NEW | 231269200 | $6.5K | 829,000 | 0.0% |
| Immatics N.v(IMTX)A | SHS | N44445109 | $6.2K | 478,987 | 0.0% |
| Protagonist Therapeutics Inc(PTGX)A | COM | 74366E102 | $6.1K | 346,000 | 0.0% |
| Inspire MED SYS Inc(INSP)A | COM | 457730109 | $6.1K | 26,000 | 0.0% |
| Nevro Corp(NVROEUR)A | COM | 64157F103 | $5.9K | 51,000 | 0.0% |
| Chinook Therapeutics Inc(290A)A | COM | 16961L106 | $5.9K | 465,000 | 0.0% |
| Syros Pharmaceuticals IncA | COM | 87184Q107 | $5.7K | 1,272,412 | 0.0% |
| Insmed Inc(INSM)A | COM PAR $.01 | 457669307 | $5.6K | 203,354 | 0.0% |
| Ocular Therapeutix Inc(OCUL)A | COM | 67576A100 | $5.6K | 556,000 | 0.0% |
| Avidity Biosciences Inc(RNA)A | COM | 05370A108 | $5.5K | 225,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)PutA | COM | 03753U106 | $5.5K | 166,700 | 0.0% |
| Kaleyra Inc(KLR1USD)A | COM | 483379103 | $5.3K | 484,592 | 0.0% |
| Iveric BIO Inc(OPHTEUR)A | COM | 46583P102 | $5.3K | 328,101 | 0.0% |
| Haemonetics Corp Mass(HAE)A | COM | 405024100 | $5.2K | 74,000 | 0.0% |
| Myriad Genetics Inc(MYGN)A | COM | 62855J104 | $5.1K | 158,000 | 0.0% |
| Natera Inc(NTRA)A | COM | 632307104 | $5.1K | 45,500 | 0.0% |
| Quidel Corp | COM | 74838J101 | $5.1K | 37,500 | 1.2% |
| MEI Pharma IncA | COM NEW | 55279B202 | $5.0K | 1,828,066 | 0.0% |
| Nocturne Acquisition CorpA | ORDINARY SHARES | G6580S114 | $5.0K | 500,000 | 0.0% |
| Keros Therapeutics Inc(KROS)A | COM | 492327101 | $5.0K | 126,000 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD)A | COM | 00773J103 | $4.8K | 609,689 | 0.0% |
| Codexis Inc(CDXS) | COM | 192005106 | $4.8K | 138,000 | 1.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $4.7K | 3,300,000 | 1.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $4.5K | 81,000 | 1.1% |
| Varex Imaging Corp(VREX)A | COM | 92214X106 | $4.5K | 158,000 | 0.0% |
| Avadel Pharmaceuticals PLCA | SPONSORED ADR | 05337M104 | $4.3K | 440,589 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD)A | COM | 98420X103 | $4.3K | 804,598 | 0.0% |
| Affimed N VA | COM | N01045108 | $4.1K | 665,000 | 0.0% |